CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07181954

Enrollment

746

Registered

2025-09-19

Start date

2016-01-15

Completion date

2023-12-31

Last updated

2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma (RCC)

Keywords

Renal Cell Carcinoma, Computed Tomography, MIT

Brief summary

This project intends to construct a multicenter retrospective study, retrospectively collect clinical, imaging, pathological and prognostic data of patients, establish a complete data management system, establish a prediction model based on CT radiomics characteristics by combining radiomics, and verify the internal and external sequence of the model, which will improve the preoperative clinical diagnosis level of MIT family translocation kidney cancer, and then guide personalized and precise diagnosis and treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Pathological diagnosis of RCC; 2. Have complete clinical, pathological and follow-up data; 3. Renal CT plain scan and enhanced images can be obtained from the image storage and transmission system (PACS)

Exclusion criteria

1. Patients who are not suitable for treatment: patients with severe comorbidities or unable to receive any form of treatment; 2. Combined with other malignant tumors: have been treated with other malignant tumors (or have other untreated active malignancies at the same time); 3. Patients with poor CT image quality/absence; 4. Patients with missing clinical/pathological/follow-up data

Design outcomes

Primary

Measure	Time frame
Postoperative renal tumor pathological diagnosis type	1 week

Outcome results